Top Story

Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
Featured
Breast Cancer3 Social
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Dna Genome Gene Targeted Social
Financing
Rome Therapeutics raises $72M in series B financing
Latest News
Lab Scientists Social
NIH to require international collaborators to share all data
September 22, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Bacteria Mycobacterium Tuberculosis Social
Danaher cuts cost of rapid TB test after years of pressure from activists
September 21, 2023
Parkinsons Lewy Bodies Social
Protein biomarker may aid in early Parkinsonian disorders detection
September 21, 2023
Dna Genome Gene Targeted Social
Financing
Rome Therapeutics raises $72M in series B financing
Regulatory Guidance
NIH to require international collaborators to share all data
Financing
Day Zero Diagnostics completes $16M financing round
Financing
Broken String Biosciences raises $15M in series A financing round
Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Informatics
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Breast Cancer3 Social
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Tuberculosis
Danaher cuts cost of rapid TB test after years of pressure from activists
Parkinson's
Protein biomarker may aid in early Parkinsonian disorders detection
More from LabPulse.com
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study
Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.
September 21, 2023
Genome Sequence Barcode Social
Researchers develop signature for scoring thyroid cancers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
Thyroid Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Broken String Biosciences raises $15M in series A financing round
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Dna Sequence Shadow Social
NIH’s systematic review finds AI may improve detection of underdiagnosed condition
A systematic review of earlier studies has found that artificial intelligence (AI) and machine learning (ML) can support the diagnosis of polycystic ovarian syndrome (PCOS).
September 19, 2023
Endometriosis Social
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Breast Mammo Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Lab Blood Tubes Social
MedTech Europe calls for IVDR changes, makes recommendations
Trade group MedTech Europe is calling for an overhaul of Europe’s medical technology regulatory frameworks to ensure that innovations reach patients and health systems more quickly.
September 19, 2023
Regulation Wheel Social
Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection
Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in Science Advances.
September 18, 2023
Nanotechnology Social
Moderna’s mRNA flu shot yields promising results in phase III trial
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test
Experts have raised concerns about Quest Diagnostics’ $399 consumer-initiated Alzheimer’s disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use.
September 15, 2023
Amyloid Plaque Alzheimer2 Social